Free Trial

Balchem Corporation (NASDAQ:BCPC) Position Reduced by Allspring Global Investments Holdings LLC

Balchem logo with Basic Materials background

Allspring Global Investments Holdings LLC decreased its position in shares of Balchem Corporation (NASDAQ:BCPC - Free Report) by 4.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 88,633 shares of the basic materials company's stock after selling 4,163 shares during the quarter. Allspring Global Investments Holdings LLC owned about 0.27% of Balchem worth $14,713,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of BCPC. Quadrant Capital Group LLC boosted its stake in Balchem by 8.2% during the 4th quarter. Quadrant Capital Group LLC now owns 989 shares of the basic materials company's stock valued at $161,000 after purchasing an additional 75 shares during the period. Covestor Ltd raised its holdings in shares of Balchem by 93.8% during the fourth quarter. Covestor Ltd now owns 157 shares of the basic materials company's stock valued at $26,000 after buying an additional 76 shares during the last quarter. Arizona State Retirement System boosted its position in shares of Balchem by 0.8% during the fourth quarter. Arizona State Retirement System now owns 9,413 shares of the basic materials company's stock worth $1,534,000 after buying an additional 77 shares during the period. Vident Advisory LLC boosted its position in shares of Balchem by 6.0% during the fourth quarter. Vident Advisory LLC now owns 1,421 shares of the basic materials company's stock worth $232,000 after buying an additional 80 shares during the period. Finally, Heritage Family Offices LLP grew its holdings in Balchem by 5.9% in the 1st quarter. Heritage Family Offices LLP now owns 1,504 shares of the basic materials company's stock worth $250,000 after buying an additional 84 shares in the last quarter. Institutional investors own 87.91% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the stock. Wall Street Zen downgraded shares of Balchem from a "buy" rating to a "hold" rating in a report on Wednesday, May 21st. HC Wainwright set a $180.00 target price on Balchem and gave the stock a "buy" rating in a research report on Monday, April 28th.

View Our Latest Research Report on Balchem

Balchem Price Performance

Balchem stock traded up $1.72 during midday trading on Friday, hitting $164.92. The company's stock had a trading volume of 83,019 shares, compared to its average volume of 143,109. Balchem Corporation has a 12 month low of $145.70 and a 12 month high of $186.03. The company has a quick ratio of 1.40, a current ratio of 2.44 and a debt-to-equity ratio of 0.18. The company has a market capitalization of $5.38 billion, a PE ratio of 39.55, a price-to-earnings-growth ratio of 3.56 and a beta of 0.89. The stock's 50-day moving average price is $163.40 and its 200-day moving average price is $163.06.

Balchem (NASDAQ:BCPC - Get Free Report) last released its earnings results on Thursday, April 24th. The basic materials company reported $1.22 EPS for the quarter, missing analysts' consensus estimates of $1.25 by ($0.03). The business had revenue of $250.52 million during the quarter, compared to the consensus estimate of $245.70 million. Balchem had a return on equity of 12.01% and a net margin of 14.16%. The firm's revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.03 earnings per share. Analysts anticipate that Balchem Corporation will post 4.64 earnings per share for the current fiscal year.

Balchem Company Profile

(Free Report)

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.

Recommended Stories

Institutional Ownership by Quarter for Balchem (NASDAQ:BCPC)

Should You Invest $1,000 in Balchem Right Now?

Before you consider Balchem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Balchem wasn't on the list.

While Balchem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines